Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


Does TGA really 'consult'?

Posted 18 January 2021 PM

The TGA's relationship with pharma is under the spotlight with a survey revealing just half of industry respondents believed the TGA genuinely considered participant input during consultations and about the same number felt it did not clearly explain reasons for final outcomes.

The TGA Stakeholder Survey 2020 questioned respondents who had participated in a consultation with the TGA over the past 12 months about their experience. Answers were received from the medical products industry including the makers of prescription and over the counter medicines, the producers of blood and/or tissue products as well as medical devices and complementary medicines.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
How not to reform the PBAC
In the face of deep change, is piecemeal enough?
Approvals Action
New registrations for seizures and HIV
Eisai and ViiV add to their core franchises
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas